Literature DB >> 12954992

Analysis of prothrombotic mechanisms and endothelial perturbation during treatment with angiogenesis inhibitors.

Bart C Kuenen1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12954992     DOI: 10.1159/000073281

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


× No keyword cloud information.
  8 in total

Review 1.  Approach to chemotherapy-associated thrombosis.

Authors:  Peter Oppelt; Anthony Betbadal; Lalitha Nayak
Journal:  Vasc Med       Date:  2015-04       Impact factor: 3.239

2.  Fournier's gangrene during lenvatinib treatment: A case report.

Authors:  Martina Barone; Giorgio Grani; Valeria Ramundo; Tiziana Garritano; Cosimo Durante; Rosa Falcone
Journal:  Mol Clin Oncol       Date:  2020-04-10

3.  Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab.

Authors:  Timo A Auer; Mirjam Renovanz; Federico Marini; Marc A Brockmann; Yasemin Tanyildizi
Journal:  J Neurooncol       Date:  2017-05-29       Impact factor: 4.130

Review 4.  Cardiotoxicity of molecularly targeted agents.

Authors:  Nadia Hedhli; Kerry S Russell
Journal:  Curr Cardiol Rev       Date:  2011-11

5.  Systemic coagulation parameters in mice after treatment with vascular targeting agents.

Authors:  Maike Unruh; Andrea Grunow; Claudia Gottstein
Journal:  Thromb J       Date:  2005-12-10

6.  Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication.

Authors:  Rebecca A Kasl; Heather M Kistka; Justin H Turner; Jessica K Devin; Lola B Chambless
Journal:  J Neurol Surg Rep       Date:  2015-08-24

7.  A Fatal Brain Stroke in Patient with Advanced Breast Cancer Treated with Bevacizumab: A Case Report.

Authors:  Germano Domenico; Tinessa Vincenza; Barletta Emiddio; Turitto Dino; Muccio Carmine Franco; Daniele Bruno
Journal:  World J Oncol       Date:  2011-01-01

8.  Elucidating the correlation between treatment with tyrosine kinase inhibitors and mean platelet volume in patients with metastatic renal cell cancer.

Authors:  Seyda Gunduz; Hasan Mutlu; Mukremin Uysal; Hasan Senol Coskun; Hakan Bozcuk
Journal:  Oncol Lett       Date:  2014-09-03       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.